First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.

BACKGROUNDBisphosphonates scale back the danger of skeletal occasions in sufferers with malignant bone illness, and zoledronic acid has proven potential anticancer results in preclinical and medical research. We aimed to ascertain whether or not bisphosphonates can have an effect on… Continue Reading